Dietary Intervention in Food Allergy: Microbiome, Epigenetic and Metabolomic interactions

ERA-HDHL JFA2 “Nutrition & the Epigenome” (Epigenome)
Dietary Intervention in Food Allergy: Microbiome, Epigenetic and Metabolomic interactions
Maria Jose Torres
IBIMA. Allergy Unit- Hospital Regional de Malaga


Partner Organization Partner Country
Universidad San Pablo CEUSpain
Paul-Ehrlich-Institut (PEI)Germany
University Regional Hospital Center of NancyFrance

1. Overall project description

1.1 Summary

Cumulative evidence suggests that food allergy (FA) is associated with a multitude of environmental factors including hygiene habits, antibiotic use, lifestyle changes and, in particular, diet. Changes in nutrition can result in dysbiosis of the skin, gut, and lung microbiota and generate changes in microbial the metabolites produced, which may in turn produce epigenetic modifications. Current evidence supports the view that epigenetic mechanisms are involved in immune regulation and may represent a key-missing piece of the etiological puzzle for FA, at the interface between the environment and the genome. Dietary fibre can change the gut microbiota composition and therefore cause epigenome changes promoting health. Pectin is one type of dietary fibre that can exert immune regulation and mouse studies have shown its capability to prevent and even cure respiratory allergies.
DIFAMEM aims to investigate the effects of FA treatment through intervention with a prebiotic dietary component, pectin, and using peach allergy as a model.

This project will advance our understanding on how the interaction between dietary components and gut microbiota composition leads to epigenetic changes that provoke the immune modulation, and establish new strategies for dietary intervention in FA, with potential applications for other immune-related diseases.

1.2 Highlights

  1. The preparation of peach allergen extracts is optimised and the experimental mouse allergy model reflecting allergic sensitisation is almost established. Data showed intraperitoneal sensitisation with peach extract rather than using the purified peach allergen and subsequent challenge with peach extract is likely to induce IgE response and allergic symptoms.    

  2. We have developed and optimised the analytical methodologies for faeces and serum samples. In faeces, a methodology adapted from Zhao L, et al. 2017 encompassing compounds from the gut microbiota - host co-metabolism, such as fatty acids, amino acids, phenols and indoles, and short chain fatty acids, has been established. Also in faeces, a methodology to obtain the profile of bile acids (primary, secondary, and conjugates) and vitamin D metabolites has been developed. In serum a targeted methodology to quantify metabolites related to energy metabolism, lysophospolipid, and sphingolipid metabolisms has been optimised.

  3. Due to solubility characteristics two pectin varieties that are not used for gel formation were identified to be analysed for application in vivo: Pectin with low molecular weight as Herbapekt SF 50-LV (apples, 57% esterification) and Pectin Classic CU 901 (citrus, 7.3 % esterification).

4. Impact

4.1 List of publications

AuthorsTitleYear, Issue, PPPartners NumberDoiPdf

4.2 Presentation of the project

Target groupAuthorsMeans of communicationHyperlinkPdf
CitizensIBIMASocial networks (Facebook, Twitter & Linkedin)

4.3 List of submitted patents and other outputs

Patent licencePartners involvedYearInternational eu or national patentCommentPdf

WU Logo
This project has received funding from the European Union’s
H2020 Research and Innovation Programme under grant agreement n.696300

We use cookies to improve our website and your experience when using it. By continuing to navigate this site, you agree to the cookie policy. To find out more about the cookies we use and how to delete them, see our privacy policy.

  I accept cookies from this site.
EU Cookie Directive Module Information